1. Home
  2. TIL vs GSIW Comparison

TIL vs GSIW Comparison

Compare TIL & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

N/A

Current Price

$7.18

Market Cap

48.4M

Sector

Health Care

ML Signal

N/A

GSIW

Garden Stage Limited

HOLD

Current Price

$26.64

Market Cap

42.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIL
GSIW
Founded
2018
2016
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.4M
42.6M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
TIL
GSIW
Price
$7.18
$26.64
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$125.00
N/A
AVG Volume (30 Days)
10.3K
10.4K
Earning Date
05-08-2026
08-04-2026
Dividend Yield
N/A
N/A
EPS Growth
6.06
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.67
$0.05
52 Week High
$33.83
$38.55

Technical Indicators

Market Signals
Indicator
TIL
GSIW
Relative Strength Index (RSI) 37.32 38.09
Support Level $6.85 $0.11
Resistance Level $8.30 $33.00
Average True Range (ATR) 0.19 1.43
MACD -0.02 -0.43
Stochastic Oscillator 21.05 0.00

Price Performance

Historical Comparison
TIL
GSIW

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: